| Dr Carlos Galvani, MD | |
|
1415 Tulane Ave, New Orleans, LA 70112-2600 | |
| (504) 988-6855 | |
| Not Available |
| Full Name | Dr Carlos Galvani |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 28 Years |
| Location | 1415 Tulane Ave, New Orleans, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003916883 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 036116676 (Illinois) | Secondary |
| 208600000X | Surgery | 42464 (Arizona) | Secondary |
| 208600000X | Surgery | 322549 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Medical Center New Orleans | New orleans, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Louisiana State University School Of Medicine In New Orleans Faculty G | 0244136448 | 380 |
News Archive
The 5α-reductase inhibitor, dutasteride, delays the clinical progression of prostate cancer in patients with prostate-specific antigen levels that have failed to reduce adequately following radical therapy for localized disease, report researchers.
Among patients with active cancer and acute symptomatic venous thromboembolism (VTE; blood clots in the deep veins), the use of the low molecular-weight heparin tinzaparin daily for 6 months compared with warfarin did not significantly reduce recurrent VTE and was not associated with reductions in overall death or major bleeding, but was associated with a lower rate of clinically relevant nonmajor bleeding, according to a study in the August 18 issue of JAMA.
Researchers at The University of Texas at San Antonio are taking diabetes education to church. Through the Building a Healthy Temple program, they're working with Hispanics who have type 2 diabetes to help them manage the disease and develop a healthier lifestyle.
Researchers at the University of California, San Diego School of Medicine have pinpointed differences in brain function that may help to explain how people with anorexia nervosa can continue to starve themselves, even when already emaciated.
New research has shown the potential for clinically available cancer treatments to treat chronic obstructive pulmonary disease.
› Verified 8 days ago
| Entity Name | Administrators Of The Tulane Educational Fund |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528014164 PECOS PAC ID: 0446163760 Enrollment ID: O20031201000636 |
News Archive
The 5α-reductase inhibitor, dutasteride, delays the clinical progression of prostate cancer in patients with prostate-specific antigen levels that have failed to reduce adequately following radical therapy for localized disease, report researchers.
Among patients with active cancer and acute symptomatic venous thromboembolism (VTE; blood clots in the deep veins), the use of the low molecular-weight heparin tinzaparin daily for 6 months compared with warfarin did not significantly reduce recurrent VTE and was not associated with reductions in overall death or major bleeding, but was associated with a lower rate of clinically relevant nonmajor bleeding, according to a study in the August 18 issue of JAMA.
Researchers at The University of Texas at San Antonio are taking diabetes education to church. Through the Building a Healthy Temple program, they're working with Hispanics who have type 2 diabetes to help them manage the disease and develop a healthier lifestyle.
Researchers at the University of California, San Diego School of Medicine have pinpointed differences in brain function that may help to explain how people with anorexia nervosa can continue to starve themselves, even when already emaciated.
New research has shown the potential for clinically available cancer treatments to treat chronic obstructive pulmonary disease.
› Verified 8 days ago
| Entity Name | Louisiana State University School Of Medicine In New Orleans Faculty G |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477582526 PECOS PAC ID: 0244136448 Enrollment ID: O20031209000661 |
News Archive
The 5α-reductase inhibitor, dutasteride, delays the clinical progression of prostate cancer in patients with prostate-specific antigen levels that have failed to reduce adequately following radical therapy for localized disease, report researchers.
Among patients with active cancer and acute symptomatic venous thromboembolism (VTE; blood clots in the deep veins), the use of the low molecular-weight heparin tinzaparin daily for 6 months compared with warfarin did not significantly reduce recurrent VTE and was not associated with reductions in overall death or major bleeding, but was associated with a lower rate of clinically relevant nonmajor bleeding, according to a study in the August 18 issue of JAMA.
Researchers at The University of Texas at San Antonio are taking diabetes education to church. Through the Building a Healthy Temple program, they're working with Hispanics who have type 2 diabetes to help them manage the disease and develop a healthier lifestyle.
Researchers at the University of California, San Diego School of Medicine have pinpointed differences in brain function that may help to explain how people with anorexia nervosa can continue to starve themselves, even when already emaciated.
New research has shown the potential for clinically available cancer treatments to treat chronic obstructive pulmonary disease.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Carlos Galvani, MD 1430 Tulane Ave # 8422, New Orleans, LA 70112-2632 Ph: (504) 988-6855 | Dr Carlos Galvani, MD 1415 Tulane Ave, New Orleans, LA 70112-2600 Ph: (504) 988-6855 |
News Archive
The 5α-reductase inhibitor, dutasteride, delays the clinical progression of prostate cancer in patients with prostate-specific antigen levels that have failed to reduce adequately following radical therapy for localized disease, report researchers.
Among patients with active cancer and acute symptomatic venous thromboembolism (VTE; blood clots in the deep veins), the use of the low molecular-weight heparin tinzaparin daily for 6 months compared with warfarin did not significantly reduce recurrent VTE and was not associated with reductions in overall death or major bleeding, but was associated with a lower rate of clinically relevant nonmajor bleeding, according to a study in the August 18 issue of JAMA.
Researchers at The University of Texas at San Antonio are taking diabetes education to church. Through the Building a Healthy Temple program, they're working with Hispanics who have type 2 diabetes to help them manage the disease and develop a healthier lifestyle.
Researchers at the University of California, San Diego School of Medicine have pinpointed differences in brain function that may help to explain how people with anorexia nervosa can continue to starve themselves, even when already emaciated.
New research has shown the potential for clinically available cancer treatments to treat chronic obstructive pulmonary disease.
› Verified 8 days ago
Danielle M Pickham, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-3000 | |
Amanda Tullos, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1430 Tulane Ave Rm 734, New Orleans, LA 70112 Phone: 501-920-4647 | |
David S Bruce, M. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1514 Jefferson Highway, New Orleans, LA 70121 Phone: 504-842-4000 | |
Dr. Robert M. Arensman, MD Surgery Medicare: Medicare Enrolled Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-4000 | |
Hernan Antonio Bazan, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1514 Jefferson Highway, 8th Floor-clinic, New Orleans, LA 07012 Phone: 504-842-4053 Fax: 504-842-5017 | |
Kiara Tulla, Surgery Medicare: Accepting Medicare Assignments Practice Location: 1430 Tulane Ave # 8622, New Orleans, LA 70112 Phone: 504-988-2306 |